[Studies on tetrahydroisoquinoline compounds. (3). Pharmacodynamics of 1-(3,4,5-trimethoxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline HC1 (AQ-110)].
D000818:Animals; D001249:Asthma / Q000188:drug therapy*; D001980:Bronchi / Q000187:drug effects*; D001993:Bronchodilator Agents / Q000494:pharmacology*; D004983:Ethanolamines / Q000494:pharmacology; D005769:Gastrointestinal Motility / Q000187:drug effects; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008688:Methacholine Compounds / Q000494:pharmacology; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects; D010121:Oxytocin / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology* / Q000633:toxicity
D001993:Bronchodilator Agents; D004983:Ethanolamines; D008688:Methacholine Compounds; D011804:Quinolines; D010121:Oxytocin; D006632:Histamine; D010208:Papaverine; D007545:Isoproterenol